January 15, 2019
Jamie Blundell, President & COO is pleased to provide the following update on Whistler Medical, one of its private holdings:
Aurora Cannabis Inc. (“Aurora Cannabis”), listed on the Toronto Stock Exchange under the symbol “ACB”, announced yesterday, entering into a letter of intent (“LOI”), to acquire all of the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation (“Whistler Medical”), in an all-share transaction valued at approximately $175 million (the “Transaction”).
Located in Whistler, British Columbia, Whistler Medical has developed one of Canada’s most iconic cannabis brands, built on quality, award-winning organic certified BC bud. The Transaction is expected to provide Aurora with a premium and differentiated organic certified product suite, expanding both its medical and adult-use offerings, and reinforcing Aurora’s presence in the well-established west coast cannabis market.
The all-share transaction includes certain milestone payments in relation to Whistler Medical achieving certain operational objectives. Including these milestone payments, the all-share transaction values Whistler at up to $175 million.
The closing of the transaction is subject to customary closing conditions, including execution of definitive documentation, completion of satisfactory due diligence, receipt of approval of the shareholders of Whistler Medical, and receipt of applicable third party and regulatory approvals and the satisfaction of other conditions customary in transactions of this nature.
For more information on this Transaction, please refer to the press release issued today by Aurora Cannabis (see press release dated January 14, 2019)
For further information please contact Cannabis Growth Opportunity Corporation:
Investor Relations Email: email@example.com